Trinity college spin-out Cellix, a developer of technology platforms for the drug discovery and diagnostics industries, has completed an €800,000 investment round.
NCB Ventures, the venture capital arm of NCB Group, led the investment.
Co-investors were OTC, a French Venture Capital fund and Enterprise Ireland. The seed capital raised will be used to finance the company's continued R&D and expansion into international markets.
The company's products combine advanced research in the areas of microfluidics and nanotechnology.